For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Sanaria Inc.

USPTO Granted Patents = 25

CIPO Patents = 6

EPO Patents = 6

Trademarks = 1

Forward Citations = 137

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

45 inventors (with patents filed for the assignee):

Stephen L Hoffman (22 out of 34 patents)

B Kim Lee Sim (8 out of 11 patents)

Richard E Stafford (7 out of 8 patents)

4. Minglin Li (7 out of 7 patents)

5. Abraham G Eappen (5 out of 5 patents)

6. Sumana Chakravarty (4 out of 4 patents)

7. Robert Seder (3 out of 9 patents)

8. Russell H Taylor (2 out of 83 patents)

9. Iulian Ioan Iordachita (2 out of 22 patents)

10. Neville Kisalu (2 out of 2 patents)

11. Azza Idris (2 out of 2 patents)

12. Barbara Flynn (2 out of 2 patents)

13. Eric R James (2 out of 2 patents)

14. Gregory Chirikjian (2 out of 7 patents)

15. Moriya Tsuji (2 out of 13 patents)

25 patents: Sort by Forward Citations

1. 12484575 - Mosquito egg cryopreservation (2025-12-02),

2. 12409213 - Live attenuated oral vaccine against shigellosis and typhoid fever (2025-09-09),

3. 12171822 - Infectious plasmodium sporozoites grown in vitro (2024-12-24),

4. 11883475 - Infectioussporozoites grown in vitro (2024-01-30),

5. 11760794 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2023-09-19),

6. 11503819 - Apparatus and method of use for an automated mosquito salivary gland extraction device (2022-11-22),

7. 11207395 - Infectious plasmodium sporozoites grown in vitro (2021-12-28),

8. 11021535 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2021-06-01),

9. 10995980 - Cryovial storage system (2021-05-04),

10. 10781419 - Mosquito salivary gland extraction device and methods of use (2020-09-22),

11. 10441646 - Infectious plasmodium sporozoites grown in vitro (2019-10-15),

12. 10272146 - Purified plasmodium and vaccine compositions (2019-04-30),

13. 10197577 - Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines (2019-02-05),

14. 9931389 - Genetic attenuation of plasmodium by B9 gene disruption (2018-04-03),

15. 9878026 - Infectious plasmodium sporozoites grown in vitro (2018-01-30),

Sanaria Inc. is a biotechnology company dedicated to the development of malaria vaccines and effective diagnostics. With a mission to eliminate malaria, Sanaria focuses on creating viable solutions to combat this global health crisis. The company's innovative approach involves developing whole-parasite vaccines by utilizing a patented technology called the Sanaria® PfSPZ. This technology is designed to stimulate a robust immune response to protect against malaria infection. Through continuous research, development, and collaborations, Sanaria Inc. strives to make a significant impact in the fight against malaria.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

25 Patents

#23 in Rockville, MD

#164 in Maryland

#12,899 in US

#24,905 in the World

Rockville, MD, United States of America

Sanaria Inc.

Forward Citations = 137

45 inventors:

Stephen L Hoffman (22 out of 34 patents)

B Kim Lee Sim (8 out of 11 patents)

Richard E Stafford (7 out of 8 patents)

4. Minglin Li (7 out of 7 patents)

5. Abraham G Eappen (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…